![Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm - Arend - 2018 - The Oncologist - Wiley Online Library Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm - Arend - 2018 - The Oncologist - Wiley Online Library](https://theoncologist.onlinelibrary.wiley.com/cms/asset/cc0857e3-e23a-46db-abe2-daf5cb8c5154/onco12670-tbl-0004.png)
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm - Arend - 2018 - The Oncologist - Wiley Online Library
![Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens - ScienceDirect Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004221007252-fx1.jpg)
Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens - ScienceDirect
![Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board | JCO Precision Oncology Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2017/po.2017.1/po.16.00046/20170529/images/large/po.16.00046t1.jpeg)
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board | JCO Precision Oncology
![IJMS | Free Full-Text | Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain IJMS | Free Full-Text | Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain](https://pub.mdpi-res.com/ijms/ijms-21-01423/article_deploy/html/images/ijms-21-01423-g001-550.jpg?1583597738)
IJMS | Free Full-Text | Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
![Frontiers | Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases Frontiers | Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases](https://www.frontiersin.org/files/Articles/273558/fmed-04-00073-HTML/image_m/fmed-04-00073-g001.jpg)
Frontiers | Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases
![Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue: Trends in Molecular Medicine Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/11c226f5-2387-4278-b5f6-4449e38e3b08/gr1_lrg.jpg)
Fertility Preservation: The Challenge of Freezing and Transplanting Ovarian Tissue: Trends in Molecular Medicine
![A systematic summary of survival and death signalling during the life of hair follicle stem cells | Stem Cell Research & Therapy | Full Text A systematic summary of survival and death signalling during the life of hair follicle stem cells | Stem Cell Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13287-021-02527-y/MediaObjects/13287_2021_2527_Fig7_HTML.png)
A systematic summary of survival and death signalling during the life of hair follicle stem cells | Stem Cell Research & Therapy | Full Text
![The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms | Leukemia The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-022-01620-2/MediaObjects/41375_2022_1620_Fig1_HTML.png)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms | Leukemia
![The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms | Leukemia The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-022-01620-2/MediaObjects/41375_2022_1620_Fig2_HTML.png)